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Introduction
A severe cobalamin (Cbl, vitamin B12) defi-
ciency can occur with several disorders, involving
different organs and systems, including blood,
bowel, nervous system and eyes(1-4). Although most of
patients have predominant haematological manifes-
tations, presence of neurological involvement, in
absence of blood count alterations, was just
described in literature.
Moreover, a folic acid supplement increases the
risk of purely neurological presentation, because it
masks the hematological effects of vitamin B12 defi-
ciency. First neurologic onset is represented by
numbness and limbs tingling, followed by progres-
sive spastic paresis and ataxia.
Perception of deep touch, pressure and vibra-
tion are generally reduced, Babinsky and Romberg
signs may be positive, and, finally, evoked potential
tests are, sometimes, abnormal. Possible, although
rare, are signs of cerebellum dysfunction, peripheral
neuropathy, sphincter disturbances, optic atrophy and
orthostatic hypotension(5-9).
Histological demyelinating lesions can be
pointed out, followed by axonal degeneration and
neuronal death, mainly interesting posterior and lat-
eral cords of the spinal cord. Rare involvement of
peripheral nerves, brain cortex and cerebellum may
be demonstrated too. The lesions are visible as multi-
ple hyperintense areas in T2-MRI(10,11). Neurologic
disorders completely regress after Cbl administra-
tion(12,13).
In this report, we describe the case of a vegetar-
ian man aged 48, suffering from celiac disease, under
gluten-free diet, affected with hypovitaminosis B12-
related multiple sclerosis-like neurological manifes-
tations, in absence of hematological disorders and/or
other symptoms or signs of organ distress.
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SUMMARY
A severe cobalamin (vitamin B12) deficiency can occur with several disorders, involving different organs and systems, includ-
ing blood, bowel, nervous system and eyes. Although most important features characterizeing this deficiency are usually haematolog-
ical ones, presence of neurological involvement, in absence of blood count alterations, was just described in literature. Here we
reported the case of a forty-eight years old male, suffering from celiac disease for, approximately, 5 years, vegetarian, which was
admitted to our Department, referring dysesthesia of left lower limb, decreased libido and erectile dysfunction. Vitamin B12 deficien-
cy was proved, even in absence of blood count alteration, and treated with vitamin supplement, resulting in complete remission of
symptoms.
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Case report
A forty-eight years old man, suffering from
celiac disease for, approximately, 5 years, under
gluten-free diet, and vegetarian for more than 10
years, was admitted to our Department, in February
2006, referring dysesthesia, starting from the left
inguinal region and spanning the entire ipsilateral
lower limb for about seven months, followed, after
five months, by decreased libido and erectile dys-
function.
In November 2000, due to familiar detection
of celiac disease (brother and nephew), the patient
underwent antitransglutaminase and antiendomysial
antibody assay and upper endoscopy, with duodenal
biopsy, which supported celiac disease diagnosis.
Therefore, patient started a gluten-free diet and
underwent to periodical outpatient follow-up,
which showed good general clinical condition, no
abnormalities in physical examination, normal rou-
tine blood chemistry, except for slightly increased
transaminases, hyposideremia and hypoferritine-
mia. Adherence to gluten-free diet led to negativity
of serological assay for antitransglutaminase and
antiendomysial antibodies.
In June 2005, he reported the onset of numb-
ness, described as “pulse-vibration”, from the left
groin, extending to the entire ipsilateral lower
extremity, followed, in November of the same year,
from decreased libido and erectile dysfunction.
Nothing notable was founded during physical
examination, except for neurological examination,
which showed asymmetry of tendon reflexes, more
vivid on the right. For this reason, a brain MRI with
intravenous contrast, which documented “multiple
periventricular and subcortical hyperintense
lesions”, and a full spine MRI with intravenous
contrast, with detection of “hyperintensities at the
level of D9-D10, disc protrusions at L3-L4 and L4-
L5”, were performed. The reports suggested a
“demyelinating leukoencephalopathy” diagnosis.
In February 2006, patient was admitted to the
“Centre for Studies of Multiple Sclerosis” in
Gallarate (Varese, Italy), where blood tests were
performed, results all within the normal ranges,
except for hypovitaminosis B12 (51 pmol/L, nor-
mal range 156-672 pmol/L) and hypercholes-
terolemia. In addition, the patient underwent to
ECG, acoustic, visual and somatosensory evoked
potentials, and cerebrospinal fluid examination, all
proving within normal limits. Due to negativity of
cerebrospinal fluid data, which did not support the
demyelinating leukoencephalopathy diagnosis,
“multifocal leukoencephalopathy under clinical sur-
veillance, in patient affected with celiac disease,
hypovitaminosis B12, and dyslipidemia” was diag-
nosed. Low-dose per os vitamin B12 treatment was
recommended, as well as brain and spinal cord con-
trol MRI with intravenous contrast after 6 months,
echocolordoppler imaging of carotid vessels, and
gastroenterological and andrological visits in refer-
ence centers.
The same month the patient was admitted to
our outpatient to perform upper endoscopy, with
duodenal and gastric biopsies (hiatal hernia and
chronic atrophic gastritis were pointed out) and
high-dose intramuscolar vitamine B1, B6 and B12
complex therapy was prescribed three times a
week. Moreover, he underwent sacral somatosenso-
ry evoked potentials test, with evidence of abnor-
malities. After administration of 4 doses of intra-
muscolar vitamine B1, B6 and B12 complex,
approximately one week later, the patient reported
mild dysesthesias disappearance, recovery of libido
and recapture of erectile function. This confirmed
the therapy and, moreover, folic acid, 15mg/day per
os, was added. Twenty days after, when administra-
tion of 11 doses of intramuscolar vitamine B1, B6
and B12 complex had been already performed,
therapy was changed, lowering to 1 vials/week of
intramuscolar vitamine B1, B6 and B12 complex,
and folic acid 15mg/2 days a week. Vitamin B12
assay was performed after 45 days of treatment,
showing values >1200 pg/ml (normal range 174-
878 pg/ml). Patient is still in follow-up in our
Department, according vitamin supplement treat-
ment to vitamin B12 and folate sierologic values
and occasional reported dysesthetic disturbances.
Discussion
Correct approach to hypovitaminosis B12-
related neurological presentation includes, first of
all, accurate identification of the anatomical site of
injury in order to reduce the broad etiology list.
Dysesthesia, presenting symptom in our report,
may be the result of injury in the parietal cortex,
deep white matter, thalamus, brain stem, spinal
cord, spinal nerves and peripheral nerves. Brain and
spinal cord MRI with intravenous contrast allowed,
in our case, identification of damage as “multifocal
leukoencephalopathy” or “white matter disease”.
The latter was first classified, according to
histopathological criteria, in demyelinating (charac-
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terized by destruction of the myelin sheath, by a
myelinoclastic process), dysmyelinating (usually
metabolic, centred on the unusual nature of myelin
content), hypomyelinating (marked by a reduced
production of myelin) leukoencephalopathies and
encephalopathies (associated with myelin cystic
degeneration). Pathogenic considerations joined
histopathological classification, and, to date, it must
be considered acquired and connatal (also known as
“leukodystrophies”) leukoencephalopathies.
The former, predominantly demyelinating, are
associated with late, or at least delayed onset, than
connatal variety. The main etiologic factors, respon-
sible for the histopathologic changes, are reported
in Table 1(14-16).
In our case, excluding primary hypothesis of
multiple sclerosis demyelinating multifocal
leukoencephalopathy, given negative cerebrospinal
fluid examination, and founding severe hypovita-
minosis B12, a likely vitamin deficiency origin of
neural abnormalities was supposed. Although in
many patients affected with Cbl deficiency haema-
tological manifestations, variously associated with
gastroenterological, neurological and psychiatric
ones, are predominant, a purely clinical neurologi-
cal presentation, with no deteclable abnormalities in
cell blood count, has just been described in litera-
ture. In this regard, it should be pointed out as a
folate supplement can mask hematologic effects of
vitamin B12 deficiency, increasing the risk of neur-
al damage and resulting neurological onset(17,18).
Daily minimum vitamin B12 requirement is
2.5µg/day, the only source from animal products.
The body stores, mainly in the liver, amounted to 3-
5mg and, therefore, clinical signs of vitamin intro-
duction deficiency or malabsorption appear only
after a period ranging from 2 to 5 years. In the
stomach, Cbl contained in food is released, by the
action of pepsin and gastric acid, and forms a com-
plex with the aptocorrina, a glycoprotein secreted in
saliva. In duodenum, pancreatic proteases degrade
aptocorrina, releasing Cbl, which can, then, bound
intrinsic factor (IF), a glycoprotein produced by
gastric parietal cells. The complex Cbl-IF reaches
terminal ileum, where it binds to specific receptors
(cubiline) present within enterocytes brush border.
After endocytosis, the complex enters the cells, IF
is degradated and Cbl bind to transcobalamin
(TCII), and, finally, enter the portal circulation.
Once binding by specific cells receptors, TCII-Cbl
complex is degraded and Cbl released into the cyto-
plasm. In humans there are 2 metabolically active
Cbl forms: methylcobalamin and adenosylcobal-
amin. The former is required for methionine syn-
thase, which catalyses the homocysteine conversion
to methionine. The latter, however, is necessary for
the methylmalonyl-CoA conversion to succinyl-
CoA. Reduction of first metabolic way, which
cooperates with folate, results in a S-adenosylme-
thionine deficiency, which reduces methylation of
cytosine and thymidine acid, and cause erroneous
DNA incorporation of uracil instead of thymine.
Reduced DNA synthesis generates megaloblasts,
and reaction blocking cause accumulation of homo-
cysteine too. A reduced activity of the second path-
way results in an increase of methylmalonyl-CoA
and its hydrolysis product (i.e. methylmalonic
acid), and a reduced succinate availability(1-4,19-21).
The most important causes of vitamin B12 deficien-
cy are listed in Table 2. 
To date, pathogenesis of neurological disorders
in patients affected with Cbl deficiency has not been
elucidated. Some authors argue that neurological
damage can be attributed, at least in part, to methio-
nine deficient synthesis. Further evidences pointed
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I. Non infectious inflammatory disorders character
• Multiple sclerosis and its variants
• Acute Disseminated Encephalomyelitis (ADEM)
II: Infectious-inflammatory disorders
• Congenital CMV infection
• CMV subacute encephalitis 
• HIV subacute encephalitis 
• Subacute sclerosing panencephalitis
• Progressive multifocal leukoencephalitis
• Other infections
III. Hypoxic-ischemic disorders
• Cerebral Autosomal Dominant Arteriopathy with Subcortical
Infarcts and Leukoencephalopathy (CADASIL)
• Periventricular leukomalacia
• Polycystic leukoencephalopathy
• Delayed hypoxic-ischemic demyelination
• Subcortical arteriosclerotic encephalopathy (Biswanger
disease)
• Aging







Table 1: pathophysiological classification of white mat-
ter disease
out abnormal methylmalonyl-CoA and its precursor
(i.e. propionyl-CoA) storage in the tissues, with
effects on myelin fatty acid synthesis. A new
hypothesis considered Cbl deficiency-induced
abnormal synthesis of certain cytokines: as a matter
of fact, tumor necrosis Factor (TNF), which proved
to have lytic effect on myelin, is increased in cere-
brospinal fluid of experimental animals previously
gastrectomized to cause Cbl deficiency. In these
studies, neurological lesions were prevented by
intrathecal injection of anti-TNF antibody or neu-
rotrophic cytokines, such as epidermal growth factor
(EGF) or interleukin (IL)-6. Similarly, in serum of
Cbl deficiency patients, an increase of TNF and a
decrease of EGF concentrations were demonstrated,
both regressed after vitamin B12 administration(19-22).
Although Cbl deficiency present, primarily,
with degeneration of posterior and lateral cords of
spinal cord, thus causing symptoms/signs of periph-
eral neuropathy, it is possible, although rare,
involvement of peripheral nerves, cerebral cortex,
and, more rarely, cerebellar cortex. In early stages,
demyelinating lesions, visible as multiple hyperin-
tense areas on T2-MRI, represents the histological
framework. These are followed by axonal degener-
ation and, finally, by irreversible neuronal death.
The earliest neurologic manifestations are repre-
sented by numbness and tingling in the limbs, fol-
lowed by progressive spastic paresis and ataxia.
Pulse, position and kinetic sensitivity are gener-
ally reduced, Babinski and Romberg signs can be
positive, and evoked potentials are often abnormal.
Possible, although rare, are signs of cerebellar dys-
function, peripheral neuropathy, sphincter distur-
bances, optic atrophy and orthostatic hypotension(5-11).
In our case, the rapid disappearance of neuro-
logical symptoms following treatment with vitamin
B12 supplement confirms the hypothesis of “defi-
ciency leukoencephalopathy”. The mainstay of vita-
min B12 deficiency treatment is replacement, pre-
ferring parenteral administration, it being generally
linked to absorption defect. The dosage should be
adequate to vitamin B12 levels and patient clinical
manifestation, with an usual initial parenteral treat-
ment of 1000µg of Cbl for 8 weeks, followed by
1000µg of Cbl per month for life. The response is
usually quick and satisfactory, with resolution of
haematological disorders and alleviation or disap-
pearance of neurological symptoms, although the
latter are not always reversible(12,13).
In our patient, according to the reported histo-
ry of long-term vegetarianism and the proved anti-
transglutaminase and antiendomysial antibody neg-
ativity in all the controls after 2004, so excluding
malabsorption from active celiac disease, hypovita-
minosis primary cause was likely attributable to an
employment deficit(23,24). Moreover, the intake of
vegetable foods, with high folate shares, may have
influenced the absence of detectable haematological
abnormalities(18).
In conclusion, here we described a multiple
sclerosis-like neurological presentation of hypovita-
minosis B12 in a vegetarian patient affected with
celiac disease, his, MRI documented, neurological
lesions, in absence of alterations in blood count,
and his successfully treatment with parenteral
administration of vitamin B12 supplement.
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I. Inadequate intake: vegetarians “vegans” (rare)
II: Malabsorption
A. Altered release of cobalamin from food:
• Gastric achlorhydria
• Partial gastrectomy
• Gastric secretion blocking drugs
B. Insufficient production of intrinsic factor:
• Pernicious anaemia
• Total gastrectomy
• Intrinsic factor congenital absence or malfunction (rare)




• Granulomatous disorders (rare)
• Malignancies
• Bowel resection
• Imerslund-Grasbeck syndrome (rare)
D. Competition for cobalamin:
• Parasitism (i.e. tapeworms) 






• Trancobalamin II deficit
• Congenital enzyme deficiencies
• Nitrous oxide anesthesia
Table 2: vitamin B12 deficiency causes
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